National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.11.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Climate Change: National and Local Policy Opportunities in China

SSRN Electronic Journal
2007English

Dirty Laundry: Drug Formulary Exclusions

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2017English

A Framework to Guide the Optimal Development and Use of Real-World Evidence for Drug Coverage and Formulary Decisions

Journal of Comparative Effectiveness Research
Health Policy
2018English

Orphan Drug Development in China ‒ Turning Challenges Into Opportunities

Intractable and Rare Diseases Research
Medicine
2016English

Social Problems of Drug Use and Drug Policies

California Law Review
Law
1968English

National Drug Formulary Review of Statin Therapeutic Group Using the Multiattribute Scoring Tool

Therapeutics and Clinical Risk Management
2013English

From Imitation to Innovation: A Study of China's Drug R&D and Relevant National Policies

Journal of Technology Management and Innovation
Management of TechnologyInnovation
2011English

B.P.C. And National Formulary

BMJ
1955English

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy